ARTICLE | Company News
Alloksys, Cevec, PharmaCell deal
March 9, 2009 7:00 AM UTC
The partners will use Cevec's human CAP cell line to develop a recombinant human alkaline phosphatase (rhuAP) protein to treat chronic diseases, including rheumatoid arthritis. Cevec will develop and ...